Articles

Cassava Sciences Stock Will Fall Further on Data Manipulation Allegations

SAVA stock is still one of the best performers this year, but the recent allegations mean shares will fall further as the story develops. More 

Pinterest Stock’s Stay-at-Home Value is Fading Along with the Pandemic

Pinterest was unable to grow users this quarter and it is facing massive competition in the industry. Stay away from PINS stock for now. More 

Even After the Crash, Steer Clear of Workhorse Stock

Workhorse's vehicles have failed to meet customers' needs, and a bigger rival is about to IPO. All this bodes ill for WKHS stock. More 

The Bull Case For DraftKings Stock Just Keeps Getting Stronger

DKNG Stock continues to grow at an aggressive pace as it looks towards diversification by moving into other profitable business areas More 

Tilray Stock Will Say in Limbo Until the U.S. Legalizes Cannabis

Tilray stock had enjoyed a 62% run up between mid-May and mid-June after it finalized its merger with former rival Aphria. The deal made Tilray the largest Canadian cannabis producer with annual revenues of $1 billion and a 17% share of the North American retail market for the recreational drug. But the shares have since fallen back to their pre-merger level of $13 a share. More 

Afghanistan Disaster Will Be a Headache for Sundial Growers

Although SNDL stock remains a “cheap” investment, it might stay that way due to political pressure affecting Washington. More 

Moderna Japan Scare Might Offer a Small Lift to Still-Alive Novavax Stock

Although a recent controversy with competitor MRNA might lift NVAX stock in the near term, it’s not something to depend on. More